{"entity":{"type":"insider","cik":"0001250313","url":"/insider/0001250313","json_url":"/insider/0001250313.json","name":"MADDON PAUL J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":72,"n_filings":54,"first":"2005-02-14","last":"2016-04-22","span_basis":"filed_date"},"name_variants":[{"name":"MADDON PAUL J","source":"filing","n_filings":54,"first_seen":"2005-02-14","last_seen":"2016-04-22"}],"transactions":[{"id":9288958,"accession":"0001447348-16-000060","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001447348-16-000060","line_url":"/filing/0001447348-16-000060#line-1","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.9,"price_display":"4.90","price_state":"stated","total_value":24500.0,"total_display":"24,500.00","total_whole":"24,500","shares_owned_after":909891.0,"shares_owned_after_display":"909,891","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-01","filed_date":"2016-04-22","scope":"insider"},{"id":7473634,"accession":"0001441844-10-000083","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001441844-10-000083","line_url":"/filing/0001441844-10-000083#line-1","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Director, Officer (Chief Executive Officer/CSO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.9,"price_display":"4.90","price_state":"stated","total_value":24500.0,"total_display":"24,500.00","total_whole":"24,500","shares_owned_after":854057.0,"shares_owned_after_display":"854,057","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-01","filed_date":"2010-12-01","scope":"insider"},{"id":7715780,"accession":"0001441844-10-000081","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001441844-10-000081","line_url":"/filing/0001441844-10-000081#line-1","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Director, Officer (Chief Executive Officer/CSO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.76,"price_display":"4.76","price_state":"stated","total_value":23800.0,"total_display":"23,800.00","total_whole":"23,800","shares_owned_after":849057.0,"shares_owned_after_display":"849,057","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-11-01","filed_date":"2010-11-02","scope":"insider"},{"id":7595799,"accession":"0001441844-10-000075","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001441844-10-000075","line_url":"/filing/0001441844-10-000075#line-1","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Director, Officer (Chief Executive Officer/CSO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.99,"price_display":"4.99","price_state":"stated","total_value":24950.0,"total_display":"24,950.00","total_whole":"24,950","shares_owned_after":844057.0,"shares_owned_after_display":"844,057","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-10-04","filed_date":"2010-10-04","scope":"insider"},{"id":7454462,"accession":"0001441844-10-000068","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001441844-10-000068","line_url":"/filing/0001441844-10-000068#line-1","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Director, Officer (Chief Executive Officer/CSO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.1,"price_display":"4.10","price_state":"stated","total_value":20500.0,"total_display":"20,500.00","total_whole":"20,500","shares_owned_after":839057.0,"shares_owned_after_display":"839,057","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-09-01","filed_date":"2010-09-02","scope":"insider"},{"id":7715778,"accession":"0001441844-10-000066","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001441844-10-000066","line_url":"/filing/0001441844-10-000066#line-1","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Director, Officer (Chief Executive Officer/CSO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.75,"price_display":"4.75","price_state":"stated","total_value":23750.0,"total_display":"23,750.00","total_whole":"23,750","shares_owned_after":834057.0,"shares_owned_after_display":"834,057","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-02","filed_date":"2010-08-02","scope":"insider"},{"id":7697144,"accession":"0001441844-10-000065","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001441844-10-000065","line_url":"/filing/0001441844-10-000065","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Director, Officer (Chief Executive Officer/CSO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.989944,"price_display":"4.99","price_state":"stated","total_value":24949.72,"total_display":"24,949.72","total_whole":"24,950","shares_owned_after":829029.0,"shares_owned_after_display":"829,029","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-07-16","filed_date":"2010-07-19","scope":"insider","n_lines":2},{"id":7289774,"accession":"0001441844-10-000032","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001441844-10-000032","line_url":"/filing/0001441844-10-000032#line-1","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Director, Officer (Chief Executive Officer/CSO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.99,"price_display":"4.99","price_state":"stated","total_value":24950.0,"total_display":"24,950.00","total_whole":"24,950","shares_owned_after":824057.0,"shares_owned_after_display":"824,057","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-06-01","filed_date":"2010-06-02","scope":"insider"},{"id":7572688,"accession":"0001441844-10-000030","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001441844-10-000030","line_url":"/filing/0001441844-10-000030","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Director, Officer (Chief Executive Officer/CSO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.92596,"price_display":"4.93","price_state":"stated","total_value":24629.8,"total_display":"24,629.80","total_whole":"24,630","shares_owned_after":819057.0,"shares_owned_after_display":"819,057","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-05-20","filed_date":"2010-05-21","scope":"insider","n_lines":2},{"id":5684896,"accession":"0001447348-09-000020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001447348-09-000020","line_url":"/filing/0001447348-09-000020#line-1","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18500.0,"shares_display":"18,500","price_per_share":4.878,"price_display":"4.88","price_state":"stated","total_value":90243.0,"total_display":"90,243.00","total_whole":"90,243","shares_owned_after":804942.0,"shares_owned_after_display":"804,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-16","filed_date":"2009-10-19","scope":"insider"},{"id":7400225,"accession":"0001266375-07-000078","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-07-000078","line_url":"/filing/0001266375-07-000078#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":23.492,"price_display":"23.49","price_state":"stated","total_value":352380.0,"total_display":"352,380.00","total_whole":"352,380","shares_owned_after":695148.0,"shares_owned_after_display":"695,148","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-15","filed_date":"2007-10-17","scope":"insider"},{"id":8057146,"accession":"0001266375-07-000070","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001266375-07-000070","line_url":"/filing/0001266375-07-000070#line-4","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":22.026,"price_display":"22.03","price_state":"stated","total_value":264312.0,"total_display":"264,312.00","total_whole":"264,312","shares_owned_after":694969.0,"shares_owned_after_display":"694,969","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-01","filed_date":"2007-10-03","scope":"insider"},{"id":7485152,"accession":"0001266375-07-000069","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-07-000069","line_url":"/filing/0001266375-07-000069#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":23.394,"price_display":"23.39","price_state":"stated","total_value":280728.0,"total_display":"280,728.00","total_whole":"280,728","shares_owned_after":694969.0,"shares_owned_after_display":"694,969","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-17","filed_date":"2007-09-19","scope":"insider"},{"id":7619664,"accession":"0001266375-07-000068","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-07-000068","line_url":"/filing/0001266375-07-000068#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":23.765,"price_display":"23.76","price_state":"stated","total_value":285180.0,"total_display":"285,180.00","total_whole":"285,180","shares_owned_after":694969.0,"shares_owned_after_display":"694,969","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-04","filed_date":"2007-09-06","scope":"insider"},{"id":7400222,"accession":"0001266375-07-000066","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-07-000066","line_url":"/filing/0001266375-07-000066#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":23.155,"price_display":"23.16","price_state":"stated","total_value":277860.0,"total_display":"277,860.00","total_whole":"277,860","shares_owned_after":694969.0,"shares_owned_after_display":"694,969","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-15","filed_date":"2007-08-16","scope":"insider"},{"id":6996827,"accession":"0001266375-07-000065","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-07-000065","line_url":"/filing/0001266375-07-000065#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":21.232,"price_display":"21.23","price_state":"stated","total_value":254784.0,"total_display":"254,784.00","total_whole":"254,784","shares_owned_after":694969.0,"shares_owned_after_display":"694,969","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-01","filed_date":"2007-08-02","scope":"insider"},{"id":6933126,"accession":"0001266375-07-000061","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-07-000061","line_url":"/filing/0001266375-07-000061#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":21.456,"price_display":"21.46","price_state":"stated","total_value":257472.0,"total_display":"257,472.00","total_whole":"257,472","shares_owned_after":694969.0,"shares_owned_after_display":"694,969","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-07-16","filed_date":"2007-07-18","scope":"insider"},{"id":8159785,"accession":"0001266375-07-000047","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001266375-07-000047","line_url":"/filing/0001266375-07-000047#line-5","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":21.676,"price_display":"21.68","price_state":"stated","total_value":260112.0,"total_display":"260,112.00","total_whole":"260,112","shares_owned_after":694969.0,"shares_owned_after_display":"694,969","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-07-02","filed_date":"2007-07-05","scope":"insider"},{"id":7619661,"accession":"0001266375-07-000040","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-07-000040","line_url":"/filing/0001266375-07-000040#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":21.751,"price_display":"21.75","price_state":"stated","total_value":261012.0,"total_display":"261,012.00","total_whole":"261,012","shares_owned_after":657290.0,"shares_owned_after_display":"657,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-01","filed_date":"2007-06-04","scope":"insider"},{"id":7575415,"accession":"0001266375-07-000038","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-07-000038","line_url":"/filing/0001266375-07-000038#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":21.9,"price_display":"21.90","price_state":"stated","total_value":262800.0,"total_display":"262,800.00","total_whole":"262,800","shares_owned_after":657290.0,"shares_owned_after_display":"657,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-15","filed_date":"2007-05-16","scope":"insider"},{"id":7228260,"accession":"0001266375-07-000037","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-07-000037","line_url":"/filing/0001266375-07-000037#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":25.613,"price_display":"25.61","price_state":"stated","total_value":307356.0,"total_display":"307,356.00","total_whole":"307,356","shares_owned_after":657290.0,"shares_owned_after_display":"657,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-05-01","filed_date":"2007-05-03","scope":"insider"},{"id":8057131,"accession":"0001266375-07-000034","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-07-000034","line_url":"/filing/0001266375-07-000034#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":26.799,"price_display":"26.80","price_state":"stated","total_value":321588.0,"total_display":"321,588.00","total_whole":"321,588","shares_owned_after":657290.0,"shares_owned_after_display":"657,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-04-16","filed_date":"2007-04-17","scope":"insider"},{"id":7115491,"accession":"0001266375-07-000027","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001266375-07-000027","line_url":"/filing/0001266375-07-000027#line-4","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":23.846,"price_display":"23.85","price_state":"stated","total_value":286152.0,"total_display":"286,152.00","total_whole":"286,152","shares_owned_after":657117.0,"shares_owned_after_display":"657,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-04-02","filed_date":"2007-04-04","scope":"insider"},{"id":8326652,"accession":"0001266375-07-000024","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-07-000024","line_url":"/filing/0001266375-07-000024#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":22.952,"price_display":"22.95","price_state":"stated","total_value":275424.0,"total_display":"275,424.00","total_whole":"275,424","shares_owned_after":657117.0,"shares_owned_after_display":"657,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-03-15","filed_date":"2007-03-19","scope":"insider"},{"id":7228255,"accession":"0001266375-07-000023","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-07-000023","line_url":"/filing/0001266375-07-000023#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":26.486,"price_display":"26.49","price_state":"stated","total_value":317832.0,"total_display":"317,832.00","total_whole":"317,832","shares_owned_after":657117.0,"shares_owned_after_display":"657,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-03-01","filed_date":"2007-03-02","scope":"insider"},{"id":8159780,"accession":"0001266375-07-000019","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-07-000019","line_url":"/filing/0001266375-07-000019#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":29.893,"price_display":"29.89","price_state":"stated","total_value":358716.0,"total_display":"358,716.00","total_whole":"358,716","shares_owned_after":641160.0,"shares_owned_after_display":"641,160","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-02-15","filed_date":"2007-02-20","scope":"insider"},{"id":7712749,"accession":"0001266375-07-000016","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-07-000016","line_url":"/filing/0001266375-07-000016#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":29.886,"price_display":"29.89","price_state":"stated","total_value":358632.0,"total_display":"358,632.00","total_whole":"358,632","shares_owned_after":641160.0,"shares_owned_after_display":"641,160","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-02-01","filed_date":"2007-02-02","scope":"insider"},{"id":7788229,"accession":"0001266375-07-000012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-07-000012","line_url":"/filing/0001266375-07-000012#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":28.576,"price_display":"28.58","price_state":"stated","total_value":342912.0,"total_display":"342,912.00","total_whole":"342,912","shares_owned_after":641160.0,"shares_owned_after_display":"641,160","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-01-16","filed_date":"2007-01-18","scope":"insider"},{"id":7788225,"accession":"0001266375-07-000007","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001266375-07-000007","line_url":"/filing/0001266375-07-000007#line-4","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":25.677,"price_display":"25.68","price_state":"stated","total_value":308124.0,"total_display":"308,124.00","total_whole":"308,124","shares_owned_after":640987.0,"shares_owned_after_display":"640,987","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-01-03","filed_date":"2007-01-05","scope":"insider"},{"id":4121300,"accession":"0001266375-06-000113","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-06-000113","line_url":"/filing/0001266375-06-000113#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":26.139,"price_display":"26.14","price_state":"stated","total_value":313668.0,"total_display":"313,668.00","total_whole":"313,668","shares_owned_after":640987.0,"shares_owned_after_display":"640,987","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-12-15","filed_date":"2006-12-19","scope":"insider"},{"id":3989659,"accession":"0001266375-06-000109","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001266375-06-000109","line_url":"/filing/0001266375-06-000109","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":26.82025,"price_display":"26.82","price_state":"stated","total_value":321843.0,"total_display":"321,843.00","total_whole":"321,843","shares_owned_after":640987.0,"shares_owned_after_display":"640,987","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-12-01","filed_date":"2006-12-05","scope":"insider","n_lines":2},{"id":5356569,"accession":"0001266375-06-000105","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001266375-06-000105","line_url":"/filing/0001266375-06-000105","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":29.146,"price_display":"29.15","price_state":"stated","total_value":349752.0,"total_display":"349,752.00","total_whole":"349,752","shares_owned_after":640987.0,"shares_owned_after_display":"640,987","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-11-15","filed_date":"2006-11-17","scope":"insider","n_lines":2},{"id":3788866,"accession":"0001266375-06-000100","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-06-000100","line_url":"/filing/0001266375-06-000100#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":25.964,"price_display":"25.96","price_state":"stated","total_value":311568.0,"total_display":"311,568.00","total_whole":"311,568","shares_owned_after":640987.0,"shares_owned_after_display":"640,987","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-11-01","filed_date":"2006-11-02","scope":"insider"},{"id":2717614,"accession":"0001266375-06-000096","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-06-000096","line_url":"/filing/0001266375-06-000096#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":24.0,"price_display":"24.00","price_state":"stated","total_value":288000.0,"total_display":"288,000.00","total_whole":"288,000","shares_owned_after":640987.0,"shares_owned_after_display":"640,987","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-10-16","filed_date":"2006-10-17","scope":"insider"},{"id":4981164,"accession":"0001266375-06-000088","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001266375-06-000088","line_url":"/filing/0001266375-06-000088#line-4","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":23.373,"price_display":"23.37","price_state":"stated","total_value":280476.0,"total_display":"280,476.00","total_whole":"280,476","shares_owned_after":640987.0,"shares_owned_after_display":"640,987","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-10-02","filed_date":"2006-10-04","scope":"insider"},{"id":3564767,"accession":"0001266375-06-000087","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001266375-06-000087","line_url":"/filing/0001266375-06-000087","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":23.945833333333333,"price_display":"23.95","price_state":"stated","total_value":287350.0,"total_display":"287,350.00","total_whole":"287,350","shares_owned_after":640828.0,"shares_owned_after_display":"640,828","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-09-15","filed_date":"2006-09-19","scope":"insider","n_lines":4},{"id":3945937,"accession":"0001266375-06-000085","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-06-000085","line_url":"/filing/0001266375-06-000085#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":22.72,"price_display":"22.72","price_state":"stated","total_value":272640.0,"total_display":"272,640.00","total_whole":"272,640","shares_owned_after":640828.0,"shares_owned_after_display":"640,828","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-09-01","filed_date":"2006-09-06","scope":"insider"},{"id":5082486,"accession":"0001266375-06-000084","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-06-000084","line_url":"/filing/0001266375-06-000084#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":20.201,"price_display":"20.20","price_state":"stated","total_value":242412.0,"total_display":"242,412.00","total_whole":"242,412","shares_owned_after":640828.0,"shares_owned_after_display":"640,828","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-08-15","filed_date":"2006-08-16","scope":"insider"},{"id":4031540,"accession":"0001266375-06-000082","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001266375-06-000082","line_url":"/filing/0001266375-06-000082","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":21.575,"price_display":"21.58","price_state":"stated","total_value":258900.0,"total_display":"258,900.00","total_whole":"258,900","shares_owned_after":640828.0,"shares_owned_after_display":"640,828","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-08-01","filed_date":"2006-08-03","scope":"insider","n_lines":2},{"id":3745405,"accession":"0001266375-06-000081","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-06-000081","line_url":"/filing/0001266375-06-000081#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":21.102,"price_display":"21.10","price_state":"stated","total_value":253224.0,"total_display":"253,224.00","total_whole":"253,224","shares_owned_after":640828.0,"shares_owned_after_display":"640,828","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-07-17","filed_date":"2006-07-19","scope":"insider"},{"id":4981145,"accession":"0001266375-06-000073","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001266375-06-000073","line_url":"/filing/0001266375-06-000073","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250313","owner_name":"MADDON PAUL J","owner_display_name":"MADDON PAUL J","owner_url":"/insider/0001250313","role":"Officer (Chief Executive Officer/CSO), Ten percent owner","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer/CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer/CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":23.837,"price_display":"23.84","price_state":"stated","total_value":286044.0,"total_display":"286,044.00","total_whole":"286,044","shares_owned_after":592492.0,"shares_owned_after_display":"592,492","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-07-03","filed_date":"2006-07-06","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":"2006-07-03|4981131","ledger_fault":false,"count":{"value":72,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":12,"open_market":true},{"code":"S","label":"Open-market sale","n":60,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":72},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000835887","name":"PROGENICS PHARMACEUTICALS INC","url":"/issuer/0000835887","role":"Director, Officer (Chief Executive Officer/CSO), Ten percent owner","n_filings":54,"first_seen":"2005-02-14","last_seen":"2016-04-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001250313","retrieved_at":"2026-08-23T18:49:32+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}